GlassScriptPhysician profile
Claymon Stevenson
NPI 1811996739
$2,469.91
in general payments reported to CMS, 2019-2025
13 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.92 · 2022: $104 · 2023: $1,917 · 2024: $207 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,486 · Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,485.55 |
| Food and Beverage | $783.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,627.39 | 2023 | |
| Polymedics Innovations INC. | $148.97 | 2023 | |
| Organogenesis INC. | $124.08 | 2023 | Puraply |
| Amgen INC. | $109.14 | 2024 | Krystexxa |
| Angiodynamics, INC. | $83.55 | 2021 | |
| Depuy Synthes Sales INC. | $80.92 | 2022 | |
| Globus Medical, INC. | $71.44 | 2025 | Senza |
| Paratek Pharmaceuticals, INC. | $68.28 | 2021-2025 | Nuzyra |
| Reprise Biomedical, INC. | $57.34 | 2025 | Miro3d |
| Nevro Corp. | $40.10 | 2024 | Senza |
| Triad Life Sciences INC. | $22.88 | 2022 | |
| Convatec INC. | $19.38 | 2024 | |
| Smith+Nephew, INC. | $16.44 | 2023 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claymon Stevenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.